The convenience ofsubcutaneous route of drug administration and the reformulation of intravenousdrugs, reaching patent expiry, for SC delivery has provided an impetus to thedevelopment of large volume wearable injectors. In fact, according to theexperts in this field, the industry is putting in significant efforts todevelop efficient and effective drug-device combinations to deliver largevolumes of drugs over a convenient period of time.
To order this 540+page report, which features 175+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors/238.html
The USD 2.7 billion and USD 600 million (by 2030)financial opportunity within the large volume wearable injectors market for thedelivery of insulin and of non-insulindrugs, respectively, has been analyzed across the following segments:
§ Typeof Device
- Patch Pump / Injectors
- Infusion Pump / Injectors
§ ProductUsability
- Disposable
- Re-usable
§ TherapeuticArea (for non-insulin drugs)
- Neurological Disorders
- Cardiovascular Disorders
- Oncological Disorders
- Infectious Disorders
§ Key geographical regions
- North America
- Europe
- Asia Pacific
The report Large Volume Wearable Injectors Market (5th Edition), 2020-2030:Focus on Bolus, Basal and Continuous Delivery Devices.” features the following companies, which we identified tobe key players in this domain:
§ Becton Dickinson
§ Bespak (subsidiary of Consort Medical)
§ CeQur
§ Debiotech
§ Eli Lilly
§ Enable Injections
§ Insulet
§ Medtronic
§ PharmaSens
§ Roche
§ SOOIL Development
§ Sonceboz
§ Sensile Medical (acquired by Gerresheimer)
§ SteadyMed Therapeutics (acquired by United Therapeutics)
§ Tandem Diabetes Care
§ Weibel CDS (acquired by SHL Medical)
§ West Pharmaceutical Services
Table of Contents
1.Preface
2. Executive Summary
3. Introduction
4. LargeVolume Wearable Injectors: Current Market Landscape
5. ProductCompetitiveness Analysis
6. LargeVolume Wearable Injectors: Key Players
7. DrugDevice Combinations: Tabulated Profiles
8. Partnershipsand Collaborations
9. KeyAcquisition Targets
10.Patent Analysis
11. LargeVolume Wearable Injectors: Likely Drug Candidates
12. EmergingTrends on Social Media
13.Clinical Trial Analysis
14. CaseStudy: Role of CMOs in Device Development and Manufacturing
15. Regulatoryand Reimbursement Landscape for Medical Devices
16.Market Sizing and Opportunity Analysis
17. SWOTAnalysis
18.Executive Insights
19.Appendix 1: Tabulated Data
20.Appendix 2: List of Companies and Organizations
To purchase a copy,please visit https://www.rootsanalysis.com/reports/view_document/large-volume-wearable-injectors-market-4th-edition-2018-2030/238.html
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
